BioLineRx (BLRX) Tops Q2 EPS by 12c

BioLineRx (NASDAQ: BLRX) reported Q2 EPS of ($0.01), $0.12 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• FirstCash to acquire UK pawn operator Ramsdens for £206 million
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins